By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kineta Inc. 

307 Westlake Ave North
Suite 200
Seattle  Washington  98109  U.S.A.
Phone: 206-378-0400 Fax: 206-378-0408



Start Up

Company News
Kineta To Present At Symposium On Next-Generation Therapeutics For The Treatment Of Pain 4/25/2017 1:20:59 PM
Kineta RLR Agonist Demonstrates Tumor Regression And An Adaptive Immune Response In Colon Carcinoma Model 3/23/2017 8:49:31 AM
Kineta Release: KCP-400 Relieves Chronic Pain And Demonstrates Disease Modifying Effects 2/22/2017 7:40:11 AM
Kineta CEO Unveils Its Immuno-oncology Program At The BIO Investor Forum 10/20/2016 9:22:47 AM
Kineta CEO To Speak On Immuno-Oncology Panel At The BIO Investor Forum 10/4/2016 9:56:21 AM
Kineta Secures Funding To Expand Testing Of Broad Spectrum Antivirals In Zika Virus 7/26/2016 8:18:39 AM
Kineta Secures NIAID Funding To Expand Testing Of Immune Modulators 7/12/2016 7:01:15 AM
Kineta Receives Wellcome Trust Award To Advance Novel Therapeutic For Lassa Fever Into Clinical Trials 5/5/2016 8:21:19 AM
Kineta Presents Promising New Data On Novel Lassa Fever Antiviral And Broad Spectrum Innate Immune Antivirals 4/22/2016 6:48:06 AM
Kineta Announces Promising New Data For KIN 1148 – A Novel Vaccine Adjuvant For Highly Pathogenic Flu 3/31/2016 10:39:35 AM